Johnson & Johnson's Q1 Performance and Strategic Update

This chapter examines Johnson & Johnson's first-quarter performance, emphasizing adjusted profit guidance for the year and reasons for narrowing the profit range. It explores strong growth in pharmaceuticals and MedTech sectors, key clinical milestones, recent acquisitions, dividend increases, and the company's commitment to R&D investment.